Shares of Henry Schein HSIC remained unaffected after the company reported Q3 results.
Quarterly Results
Earnings per share rose 14.44% year over year to $1.03, which beat the estimate of $0.79.
Revenue of $2,840,000,000 higher by 13.19% from the same period last year, which beat the estimate of $2,470,000,000.
Outlook
Earnings guidance hasn't been issued by the company for now.
Henry Schein hasn't issued any revenue guidance for the time being.
How To Listen To The Conference Call
Date: Nov 02, 2020
Time: 10:00 AM
ET Webcast URL: https://edge.media-server.com/mmc/p/5t9phbat
Recent Stock Performance
52-week high: $73.99
52-week low: $41.85
Price action over last quarter: down 5.29%
Company Profile
Henry Schein is the largest wholesaler of dental and medical products to office-based practitioners. The company has been established for approximately 90 years and operates across nearly 30 distribution centers to offer hundreds of thousands of products to customers globally. Henry Schein also offers dental practice management products that include software products, technical, financial, and educational services. The company recently spun off its animal health business.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
|---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
